MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Capital Expenditures (2019 - 2024)

MetaVia's (MTVA) quarterly Capital Expenditures came in at $3000.0 in Q2 2024, down 40.0% on a QoQ basis from $5000.0 in Q1 2024.

MetaVia (MTVA) Capital Expenditures (2019 - 2024) Analysis & Trends

MetaVia (MTVA) has 4 years of Capital Expenditures data on file, last reported at $3000.0 in Q2 2024.

  • Quarterly Capital Expenditures changed N/A year-over-year to $3000.0 in Q2 2024, while the trailing twelve-month figure through Sep 2025 was $3000.0 (down 82.35% YoY) and the FY2025 annual result came in at $2000.0, down 75.0% from the prior year.
  • Capital Expenditures eased to $3000.0 in Q2 2024, from $5000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $37000.0 in Q3 2023 to a low of $2000.0 in Q1 2020.
  • A 3-year average of $8857.1 and a median of $4000.0 in 2023 frame the typical range for Capital Expenditures.
  • Annual changes were most pronounced in 2020 — Capital Expenditures tumbled 97.92% — and 2024, when it rose 25.0%.
  • Tracing MTVA's Capital Expenditures over 3 years: stood at $2000.0 in 2020, then surged by 350.0% to $9000.0 in 2023, then slumped by 66.67% to $3000.0 in 2024.
  • The last three Capital Expenditures figures came in at $3000.0 (Q2 2024), $5000.0 (Q1 2024), and $9000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 37.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 25.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 34.68 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -73.57 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 6.26 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 251.02 Mn
10 MetaVia 8.72 Mn -3.92 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 3,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 5,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 9,000.00
Dec 31, 2023 9,000.00
Sep 30, 2023 37,000.00
Sep 30, 2023 37,000.00
Mar 31, 2023 4,000.00
Mar 31, 2023 4,000.00
Dec 31, 2020 2,000.00
Dec 31, 2020 2,000.00
Mar 31, 2020 2,000.00
Mar 31, 2020 2,000.00
Dec 31, 2019 96,000.00
Dec 31, 2019 96,000.00
Sep 30, 2019 93,000.00
Sep 30, 2019 93,000.00